Barely Significant
← all excerpts

Simultaneous Determination of Lyso-Gb1 and Lyso-Gb3 in Plasma Using Salt-Assisted Liquid-Liquid Extraction Combined with LC-MS/MS.

ACS Omega · 2025 · PMC12756796 · PMID 41487235

2
hedged sentences
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
Statistical analysis demonstrated a highly significant difference between the two groups ( p < 0.0001).

also in 132,142 other papers

a clear trendno p-value reported
The 5 min chromatographic run and subng/mL LOQs (Lyso-Gb1 0.380 ng/mL; Lyso-Gb3 0.756 ng/mL) met all ICH M10 criteria, with consistent accuracy/precision, stability, carry-over, dilution integrity, and reinjection performance. Clinically, the assay demonstrated a clear trend of separation between Fabry patients and healthy controls and showed excellent ROC performance (AUC = 1.000) with pragmatic cutoffs (5.80 ng/mL for Lyso-Gb1; 3.334 ng/mL for Lyso-Gb3), consistent with ranges reported in previous studies.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.